<SEC-DOCUMENT>0001140361-24-022721-index.html : 20240429 <SEC-HEADER>0001140361-24-022721.hdr.sgml : 20240429 <ACCEPTANCE-DATETIME>20240429084638 ACCESSION NUMBER: 0001140361-24-022721 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20240612 FILED AS OF DATE: 20240429 DATE AS OF CHANGE: 20240429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GYRE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001124105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 562020050 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-51173 FILM NUMBER: 24886801 BUSINESS ADDRESS: STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (619) 949-3681 MAIL ADDRESS: STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST BIOSCIENCES, INC. DATE OF NAME CHANGE: 20150820 FORMER COMPANY: FORMER CONFORMED NAME: TARGACEPT INC DATE OF NAME CHANGE: 20000919 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14A <SEQUENCE>1 <FILENAME>ny20022295x2_def14a.htm <DESCRIPTION>DEF 14A <TEXT> Document 1 - file: ny20022295x2_def14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>logo_gyre.jpg <TEXT> Document 2 - file: logo_gyre.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>ny20022295x2_pc01x1.jpg <TEXT> Document 3 - file: ny20022295x2_pc01x1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>ny20022295x2_pc02x1.jpg <TEXT> Document 4 - file: ny20022295x2_pc02x1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>ny20022295x2_pvp01.jpg <TEXT> Document 5 - file: ny20022295x2_pvp01.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>ny20022295x2_pvp02.jpg <TEXT> Document 6 - file: ny20022295x2_pvp02.jpg
</DOCUMENT> </SEC-DOCUMENT>